Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance CentreA Cross-Sectional Period-Prevalence Study

被引：0
|
作者：
Betsabé Sánchez-Sánchez
Marina Altagracia-Martínez
Jaime Kravzov-Jinich
Consuelo Moreno-Bonett
Everardo Vázquez-Moreno
Juan Manuel Martínez-Núñez
机构：
[1] Metropolitan Autonomous University-Xochimilco,Division of Biological and Health Sciences, Department of Biological Systems
[2] Pfizer Laboratory,undefined
来源：
Drug Safety | 2012年 / 35卷
关键词：
Adverse Drug Reaction; Pharmaceutical Industry; Pregabalin; Adverse Drug Reaction Report; Anatomical Therapeutic Chemical Classification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The Mexican National Centre of Pharmacovigilance (CNFV) receives suspected adverse drug reaction (ADR) reports from the pharmaceutical industry, Federal States Centre of Pharmacovigilance (CEFV) and Healthcare Institution Centres of Pharmacovigilance (CIFV). The completeness of these suspected ADR reports is particularly important for the proper evaluation of drug safety.
引用
收藏
页码：837 / 844
页数：7
相关论文
共 50 条
  • [41] Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals
    Nair, Nibu Parameswaran
    Chalmers, Leanne
    Bereznicki, Bonnie J.
    Curtain, Colin
    Peterson, Gregory M.
    Connolly, Michael
    Bereznicki, Luke R.
    DRUG SAFETY, 2017, 40 (07) : 597 - 606
  • [42] Adverse drug events related to COX inhibitors in patients presenting at an emergency department Cross-sectional study of prevalence and risk factors
    Pfistermeister, B.
    Dormann, H.
    Patapovas, A.
    Mueller, F.
    Sonst, A.
    Glaeser, H.
    Plank-Kiegele, B.
    Buerkle, T.
    Maas, R.
    NOTFALL & RETTUNGSMEDIZIN, 2016, 19 (08): : 671 - 678
  • [43] Prevalence and Risk Factors of Adverse Effects and Allergic Reactions after COVID-19 Vaccines in a Mexican Population: An Analytical Cross-Sectional Study
    Granados Villalpando, Jesus Maximiliano
    Romero Tapia, Sergio de Jesus
    Baeza Flores, Guadalupe del Carmen
    Ble Castillo, Jorge Luis
    Juarez Rojop, Isela Esther
    Lopez Junco, Frida Isabel
    Olvera Hernandez, Viridiana
    Quiroz Gomez, Sergio
    Ruiz Quinones, Jesus Arturo
    Guzman Priego, Crystell Guadalupe
    VACCINES, 2022, 10 (12)
  • [44] Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010–2020: A Cross-Sectional Study
    Michael Phan
    Carmen Cheng
    Vivian Dang
    Eileen Wu
    Monica A. Muñoz
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 1062 - 1073
  • [45] Comment on: "Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals"
    Kargar, Mona
    Ahmadvand, Alireza
    Gholami, Kheirollah
    DRUG SAFETY, 2018, 41 (03) : 321 - 322
  • [46] Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study
    Hu, Wen
    Tao, Yun
    Lu, Yun
    Gao, Suyu
    Wang, Xuanxuan
    Li, Wenjing
    Jiang, Qiaoli
    Lin, Likai
    Sun, Feng
    Cheng, Hong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”
    Mona Kargar
    Alireza Ahmadvand
    Kheirollah Gholami
    Drug Safety, 2018, 41 : 321 - 322
  • [48] Knowledge, Attitude, and Practice of Medical, Pharmacy, and Nursing Students Towards Pharmacovigilance and Adverse Drug Reaction Reporting at University of Gondar College of Medicine and Health Sciences, Northwest Ethiopia: A Cross-Sectional Study
    Tigabe, Masho
    Fentahun, Tekel Abaynesh
    Sema, Faisel Dula
    ADVANCES IN MEDICAL EDUCATION AND PRACTICE, 2021, 12 : 1129 - 1139
  • [49] Evaluation of Global trigger tool as a medication safety tool for adverse drug event detection—a cross-sectional study in a tertiary hospital
    Ville Valkonen
    Kaisa Haatainen
    Susanna Saano
    Miia Tiihonen
    European Journal of Clinical Pharmacology, 2023, 79 : 617 - 625
  • [50] Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study
    Phan, Michael
    Cheng, Carmen
    Dang, Vivian
    Wu, Eileen
    Munoz, Monica A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (05) : 1062 - 1073
12345